Fluidigm (NASDAQ: FLDM) and Castlight Health (NYSE:CSLT) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ownership, profitability, earnings and risk.

Volatility & Risk

Fluidigm has a beta of 3.37, suggesting that its stock price is 237% more volatile than the S&P 500. Comparatively, Castlight Health has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500.

Earnings and Valuation

This table compares Fluidigm and Castlight Health’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fluidigm $104.45 million 2.22 -$75.98 million ($2.23) -2.69
Castlight Health $101.70 million 5.19 -$58.54 million ($0.47) -8.40

Castlight Health has lower revenue, but higher earnings than Fluidigm. Castlight Health is trading at a lower price-to-earnings ratio than Fluidigm, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

93.3% of Fluidigm shares are owned by institutional investors. Comparatively, 42.6% of Castlight Health shares are owned by institutional investors. 4.7% of Fluidigm shares are owned by company insiders. Comparatively, 24.4% of Castlight Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.


This table compares Fluidigm and Castlight Health’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Fluidigm -68.27% -134.35% -17.77%
Castlight Health -45.14% -32.57% -22.14%

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Fluidigm and Castlight Health, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fluidigm 0 0 1 0 3.00
Castlight Health 1 3 3 0 2.29

Fluidigm currently has a consensus target price of $9.00, indicating a potential upside of 50.00%. Castlight Health has a consensus target price of $5.34, indicating a potential upside of 35.23%. Given Fluidigm’s stronger consensus rating and higher probable upside, research analysts clearly believe Fluidigm is more favorable than Castlight Health.

About Fluidigm

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.

About Castlight Health

Castlight Health, Inc. offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent. Its products deliver employee engagement and enable employers to integrate benefit programs into a single platform available to employees and their families. Its health benefits platform engages external data and its substantial user base to provide a single, end-to-end solution that engages employees through personalized and relevant communications. Its offering provides employers the opportunity to communicate, measure, and get value out of their benefits and programs on a real-time basis. It offers cross-sell products, such as Castlight Action, Castlight Pharmacy, Castlight Dental, Castlight Elevate, Castlight Protect and Castlight Rewards.

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with Analyst Ratings Network's FREE daily email newsletter.